HIV patients in Scotland with high levels of resistance to protease inhibitors could soon benefit from treatment with tipranavir boosted with ritonavir (tipranavir/r) following acceptance by the Scottish Medicines Consortium (SMC).
HIV patients in Scotland with high levels of resistance to protease inhibitors could soon benefit from treatment with tipranavir boosted with ritonavir (tipranavir/r) following acceptance by the Scottish Medicines Consortium (SMC).
